Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
The Impact of ICH Q5A R2 on the Biopharmaceutical MarketThe Impact of ICH Q5A R2 on the Biopharmaceutical Market
BPI Contributor
February 14, 2024
Horst Rupach, Executive Director, Scientific and Portfolio Global Biologics, Charles River Laboratories, spoke with Brandy Fidler from Informa Connect Life Sciences about ICH Q5A R2. Rupach will be giving a presentation at BPI West in San Diego in March 2024.
Read the eBook and watch the pre-event interview here.
About the Author
You May Also Like
Webinars
Mar 18 - Mar 21, 2025
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More
